CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS;CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
发明人:
Nicolas POTTIER,Bernard MARI,Brice MARCET,Pascal BARBRY
申请号：
US15397351
公开号：
US20170183658A1
申请日:
2017.01.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the use of the miRNA expression profile, particularly of miR-199a-5p, and the target genes regulated thereby for the diagnosis, prognosis and use of miR-199a-5p inhibitors for treating fibroproliferative disorders.
